FBInvestor
Stocks / Halozyme Therapeutics Inc
Institutional Ownership

Halozyme Therapeutics Inc

CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.